Clinical trial Recruiting at 1 site Observational Ages 18 and up

MRI-guided cryoablation for pain relief in the head, neck, and spine

Official title: MRI-Guided Cryoablation of Head, Neck and Spine Nerves and Facets Using the Advanced Multimodality Image Guided Operating(AMIGO) Suite

Run by Brigham and Women's Hospital · NCT01788410 · Data updated 2026-11-12

This study is testing a new way to relieve pain in the head, neck, and spine by using a special technique that freezes pain-causing nerves to see if it works better than regular treatments for people with joint or nerve issues.

More Neuropathy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorBrigham and Women's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedMay 2013
Main results expectedMay 2030
Study endsMay 2030
Registry record updatedAugust 8, 2023
Trial IDNCT01788410 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with facet joint disease or pain from nerve compression who are suitable for minimally invasive procedures.

Probably not a fit

Patients with contraindications to MRI or those who are pregnant or breastfeeding may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to alleviate pain in patients suffering from facet joint disease or nerve compression in the head and neck. It utilizes MRI-guided cryoablation, a minimally invasive technique that destroys pain-transmitting nerves to provide longer-lasting pain relief compared to traditional methods. The procedure is performed in the Advanced Multimodality Image Guided Operating Suite (AMIGO) at Brigham and Women's Hospital, which enhances precision and reduces risks associated with nerve ablation. Participants will undergo imaging and treatment to assess the efficacy of this innovative approach.

Why it matters

Potential benefit: If successful, this approach could provide significant and prolonged pain relief for patients with chronic pain conditions.

How similar studies have gone: Other studies have shown promising results with similar cryoablation techniques, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must be willing and able to sign a written informed consent document.
* Patients must have facet joint disease or pain due to a damaged or compressed nerve that would benefit from a minimally invasive image-guided procedure (i.e., adjacent to critical structures, better visualized under 3 Tesla MRI than CT)
* Subjects must be able to adhere to the visit schedules and attend pre and post imaging.
* Participants must be at least 18 years of age
* Participants must have an estimated life expectancy of \>8 weeks in the opinion of the clinician.

  * Patients with radiculopathy must have the cause of pain confirmed by a nerve block within 3 months prior to ablation

Exclusion Criteria:

* Contraindications to MRI and Gadolinium- (i.e. estimated Glomerular Filtration Rate \<60ml/min, metal clips)
* Pregnant or breastfeeding woman are excluded from this research.

Where it's running

  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.